['pancreatic cancer']
['mm-141', 'placebo', 'gemcitabine', 'nab-paclitaxel']

        Inclusion Criteria:

          -  Metastatic adenocarcinoma of the pancreas. Patients with islet cell neoplasms are not
             eligible.

          -  Patient must have received no prior radiotherapy, surgery, chemotherapy, or
             investigational therapy for the treatment of metastatic disease.

          -  Blood sample sent for free IGF-1 testing

          -  ECOG performance status (PS) of 0 or 1

        Exclusion Criteria:

          -  Patients who only present with localized disease

          -  Patients with CNS malignancies (primary or metastatic)

          -  Clinically significant cardiac disease
      